Next Generation Sequencing Market Size, Share, Trends, Analysis, Report and Forecast to 2022
According to Stratistics MRC, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015.
GAITHERSBURG, MARYLAND, US, May 17, 2017 /EINPresswire.com/ -- According to Stratistics MRC, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to 2022. The growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. However, factors such as accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. The rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.Request for sample here:
http://www.strategymrc.com/report/next-generation-sequencing-market-2016
In technology, sequencing by synthesis (SBS) segment is anticipated to move with a highest CAGR during forecast period. Diagnostics in application segment holds the largest share and is expected to grow at highest CAGR during forecast period. Research institutions held the largest market share in end user segment. North America dominates the global next generation sequencing market followed by Europe owing to rising government support towards research and development. Asia pacific is expected to grow at a faster rate during the forecast period due to the unmet market demand and increasing investments for development of healthcare.
Order the complete report here:
http://www.strategymrc.com/report/next-generation-sequencing-market-2016
Some of the key players in the market include Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc., Partek, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd., Macrogen Inc., Life Technologies Corporation, Illumina, Inc., Genomatix Software GmbH, GATC Biotech Ag., Eurofins Scientific, DNASTAR Inc., Biomatters, Ltd., Beijing Genomics Institute and Agilent Technologies, Inc.
For More, Please Visit: http://www.strategymrc.com/report/next-generation-sequencing-market-2016
Follow us on Twitter:
https://twitter.com/StratisticsMRC
Follow us on LinkedIn:
https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
Follow us on Facebook:
https://www.facebook.com/pages/Stratistics/1623521354597831
About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
For more information, please visit:
http://www.strategymrc.com/
James Lamb
Stratistics Market Research & Consulting Pvt Ltd
+1-301-202-5929
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
